Australia’s opportunity to turn biotech into global growth
How Australian biotech can use funding, clinical research and global markets to drive growth.
Beyond the numbers: Explore the trends and ideas shaping Australian business. Listen now.
By: Rebecca Iwanuscha, Bianca Patrick
08 Feb 2024 4 min read

The activities involved creating customised basketball shoes for a professional basketball player and were found to not have been undertaken for the purpose of creating new knowledge, a systematic process of work, or resolving a technical uncertainty. The Tribunal upheld the decision of the Commissioner of Taxation to deny the claim in full.
The Applicant stated that the development of the customised basketball shoes took considerable time and there were many prototypes, revisions, and failures throughout the development process. In addition, it was noted the evidence provided by the Applicant included emails, WeChat messages, photographs and videos, as well as a document outlining the six different prototypes.
Important factors below were considered before reaching a conclusion:
The AAT found the activities involved the modification of existing knowledge to suit the personal preferences or requirements of an individual and held none of the activities were core R&D activities as defined in the ITAA 1997.
Case law can show applicants what evidence may be useful or not in deciding whether eligible R&D activities have occurred. Some of the main lessons from the case are:
Case law is an important source of information for Grant Thornton’s Innovation Incentives team. Each case is considered and studied to determine the potential consequences for different stakeholders. Contact Grant Thornton’s R&D Tax experts below to find out how this case could be related to your claim.
How Australian biotech can use funding, clinical research and global markets to drive growth.
R&D Tax Incentive reforms, RDTI reforms, R&D tax offset, innovation incentives, refundable R&D offset, non-refundable R&D offset, supporting R&D activities, Treasury consultation, research and development tax incentive, Federal Budget 2026-27, R&D tax changes, Australia R&D incentives, Innovation Incentives, R&D claims
In this edition of our Australian International Tax Update, we summarise recent significant Australian tax developments, examine their practical impact, and outline actions that multinational groups, foreign investors, private equity funds and international advisers should consider.